Ignite Creation Date:
2024-05-06 @ 8:57 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02864121
Status:
COMPLETED
Last Update Posted:
2020-06-16
First Post:
2016-05-11
Brief Title:
Oncogenous HPV DNA Integration Intégration De lADN Des HPV Oncogènes
Sponsor:
CHU de Reims
Organization:
CHU de Reims
Study Overview
Official Title:
Association Between High-risk HPV Genome Integration Detected by Molecular Combing and Cervical Lesions Severity andor Evolution
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IDAHO
Brief Summary:
High-risk human papillomavirus HR-HPV are involved in cervical cancer development Integration of HR-HPV DNA in cellular genomes is considered as a major event in the cervical cancer development The aim of this study is to validate the integration of the HPV-HR as an appropriate biomarker of the severity of precancerous lesions and progression of cervical lesions towards cervical cancer HR-HPV integration status will be analyzed by Molecular Combing technology which allows direct and high-resolution visualization of the integration of high-risk HPV genomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None